Peter Weijmarshausen

Peter Weijmarshausen has a diverse work experience, starting with their role as CEO and Co-founder of Humane Genomics, where they are building a platform using synthetic biology to engineer cancer killing viruses targeting liver cancer. Prior to that, they co-founded and served as a Board Director at Shapeways, the largest 3D printing platform, where they successfully developed the business plan and took the company from pre-seed to beta stage. Peter also co-founded Sangine N.V., where they served as CTO and led the product and software development of the next generation DVB-RCS modem before the company was acquired by Newtec. Before Sangine, they worked at Aramiska B.V. as the Director of Engineering, where they led the technical team in building a working 2-way satellite internet service in less than a year. Additionally, they worked at Not a Number B.V. as an IT manager, responsible for setting up and managing the e-Shop and IT infrastructure for the offices in Eindhoven and Amsterdam.

Peter Weijmarshausen attended Bernardinus College, a high school, for an unknown period of time. Peter then went on to study at Eindhoven University of Technology from 1989 to 1997. The degree name and field of study for both educational experiences are unknown.